Stay updated on Pembrolizumab Post-Tx in Oligometastatic NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Post-Tx in Oligometastatic NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Post-Tx in Oligometastatic NSCLC Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    The revision tag on the page updated from v3.5.3 to v3.5.4, indicating a minor system update that does not modify study details or results displayed.
    Difference
    0.1%
    Check dated 2026-05-18T03:27:02.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    No Change Detected
  5. Check
    31 days ago
    Change Detected
    Summary
    The page’s platform/site revision label was updated from **v3.5.2** to **v3.5.3**, reflecting a behind-the-scenes release rather than a change to the clinical trial record.
    Difference
    0.1%
    Check dated 2026-04-26T15:20:16.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    Added revision: v3.5.2; removed revision: v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-19T13:30:37.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.3 to v3.5.0 on the page.
    Difference
    0.1%
    Check dated 2026-03-21T16:55:38.000Z thumbnail image
  8. Check
    82 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-07T06:49:50.000Z thumbnail image
  9. Check
    103 days ago
    Change Detected
    Summary
    The site version badge updated from v3.4.1 to v3.4.2, indicating a backend/frontend revision. No study content or functionality was changed as part of this update. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-13T17:31:15.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Post-Tx in Oligometastatic NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Post-Tx in Oligometastatic NSCLC Clinical Trial page.